Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-01 Sale |
2021-06-02 4:11 pm |
PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director |
3,900 | $32.55 | $126,935 | 43,704 (Indirect Direct) |
View |
| 2021-05-20 Sale |
2021-05-24 7:30 pm |
Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director |
1,400 | $25.15 | $35,208 | 232,326 (Indirect Direct) |
View |
| 2021-05-14 Sale |
2021-05-18 8:22 pm |
Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director |
5,874 | $25.29 | $148,582 | 233,726 (Indirect Direct) |
View |
| 2021-05-11 Sale |
2021-05-13 8:00 pm |
Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director |
100 | $25.11 | $2,511 | 239,600 (Indirect Direct) |
View |
| 2021-04-28 Sale |
2021-04-30 7:59 pm |
Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director |
200 | $25.17 | $5,034 | 239,700 (Indirect Direct) |
View |
| 2021-04-01 Sale |
2021-04-05 7:42 pm |
Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director |
100 | $25 | $2,500 | 239,900 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-02 Option Award |
2021-06-04 4:05 pm |
N/A 2031-06-01 |
YUMANITY THERAPEUTICS INC. | YMTX | Heyman Richard A. Director |
14,800 | $0 | 14,800 (Direct) |
View |
| 2021-06-01 Exercise |
2021-06-02 4:11 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director |
2,925 | $2.95 | 43,704 (Indirect) |
View |
| 2021-06-01 Exercise |
2021-06-02 4:11 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director |
975 | $975 | 43,704 (Indirect) |
View |
| 2021-06-01 Exercise |
2021-06-02 4:11 pm |
N/A 2027-08-16 |
PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director |
3,900 | $0 | 43,704 (Indirect) |
View |
| 2021-05-24 Option Award |
2021-05-25 7:01 pm |
N/A 2031-05-23 |
Metacrine Inc. | MTCR | Heyman Richard A. Director |
16,500 | $0 | 16,500 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 6:38 pm |
N/A N/A |
YUMANITY THERAPEUTICS INC. | YMTX | Heyman Richard A. Director |
1,959 | $0 | 8,117 (Direct) |
View |
| 2020-12-22 Option Award |
2020-12-28 7:10 pm |
N/A 2030-04-06 |
YUMANITY THERAPEUTICS INC. | YMTX | Heyman Richard A. Director |
11,429 | $0 | 11,429 (Direct) |
View |
| 2020-11-11 Option Award |
2020-11-12 4:14 pm |
N/A 2030-06-22 |
PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director |
45,332 | $0 | 45,332 (Direct) |
View |
Ownership |
2020-09-24 7:12 pm |
N/A 2027-08-16 |
PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director |
0 | $0 | 244,044 (Direct) |
View |
Ownership |
2020-09-16 12:06 pm |
N/A N/A |
Metacrine Inc. | MTCR | Heyman Richard A. Director |
0 | $0 | 189,019 (Direct) |
View |
Ownership |
2020-09-03 06:19 am |
N/A N/A |
BCTG Acquisition Corp. | BCTG | Heyman Richard A. Director |
0 | $0 | 40,600 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-22 5:30 pm |
N/A 2030-06-18 |
Gritstone Oncology Inc. | GRTS | Heyman Richard A. Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2020-04-28 Conversion |
2020-04-28 5:08 pm |
N/A N/A |
Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director |
62,500 | $0 | 240,000 (Indirect) |
View |